Clinical Trial Update: Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS [Phase 4]

View source ↗

Summary

Phase 4 study investigating metabolic responses to metformin in Polycystic Ovary Syndrome and how SLC22A1 gene polymorphisms may influence outcomes. The trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Polycystic Ovary Syndrome, Metformin | Phase 4 | Status: ACTIVE_NOT_RECRUITING